Winton Capital »

Kyverna Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $155k 17k 8.91

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Kyverna Therapeutics

Gilead Sciences
BlackRock
Bain Capital Life Sciences Investors
AIGH Capital Management
Deerfield Management Company
Vanguard Capital Management
T. Rowe Price Associates
Geode Capital Management
Insight Holdings
Morgan Stanley
Propel Bio Management
Woodline Partners
Millennium Management
Mbb Public Markets I
Adage Capital Partners GP

View all funds holding Kyverna Therapeutics